Inovio Pharma (INO) Income Statement

Click line-items for a historical chart and %

Revenue:
License fee and milestone revenue	2.33M
License fee and milestone revenue from affiliated entity	574.6K
Grant and miscellaneous revenue	9.41M
Total revenue	12.54M
Operating expenses:
Research and development	26.98M
General and administrative	5.76M
Gain on sale of assets
Total operating expenses	32.74M
Loss from operations	-20.2M
Other income (expense):
Interest income, net
Other income, net
Loss from investment in affiliated entity	-958.14K
Net loss	-20.76M
Net loss/ (gain) attributable to non-controlling interest	0
Net loss attributable to Inovio Pharmaceuticals, Inc.	-20.76M
Loss per common share - basic and diluted:
Net loss per share attributable to Inovio Pharmaceuticals, Inc. stockholders
Weighted average number of common shares outstanding - basic and diluted

Entities mentioned with INO